Global Progesterone Capsules Market Growth 2026-2032
The global Progesterone Capsules market size is predicted to grow from US$ 320 million in 2025 to US$ 472 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.
Progesterone Capsules are oral solid dosage forms containing progesterone, widely used for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and selected hormone replacement therapy regimens. The dosage form has a long clinical history and well-established prescribing practices. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), gelatin or plant-based capsule shells, oil-based solvent systems such as vegetable oils or medium-chain triglycerides, antioxidants and stabilizers, as well as pharmaceutical blister packaging materials; overall material costs are relatively low, while formulation stability and oral bioavailability management represent the main technical considerations. Downstream customers mainly include OB-GYN hospitals, fertility clinics, general hospital outpatient departments, and retail prescription pharmacies, with additional use in peri-menopausal hormone therapy in certain markets. The global nameplate capacity for Progesterone Capsules in 2025 is estimated at approximately 0.98 billion capsules, with actual sales of around 0.86 billion capsules. Driven by a high share of generics and intense regional competition, the global average ex-factory price is estimated at USD 0.38 per capsule. Overall industry gross margin is estimated at approximately 46%.
The market is currently in a highly mature and intensely competitive stage, characterized by a multi-regional supply base and a large number of active manufacturers. Generic products dominate, making price and accessibility the primary competitive factors. Clinical use patterns are well established and widely distributed across routine OB-GYN care and reproductive medicine settings, with limited dependence on individual brands. In most markets, progesterone capsules are regarded as standard therapies, and purchasing and prescribing behaviors are increasingly rational, with market fluctuations driven more by policy and channel dynamics than by fundamental shifts in clinical demand.
Looking ahead, overall demand is expected to follow a moderate and stable trajectory rather than experiencing significant expansion. As assisted reproduction and women?s healthcare services become more standardized, oral progesterone will continue to play a role within established treatment pathways. However, in certain clinical scenarios that emphasize patient compliance or treatment optimization, its relative advantages are being challenged by alternative dosage forms. Regionally, improving access in emerging markets will remain a key source of support, while mature markets place greater emphasis on individualized treatment strategies and patient experience.
Key growth drivers include demographic changes, delayed childbearing trends, and rising awareness of women's health, all of which provide a degree of long-term resilience to underlying demand. At the same time, a well-developed API and formulation supply chain has lowered production and entry barriers, ensuring consistent product availability. From a healthcare system perspective, mature oral formulations continue to offer advantages in cost control and ease of use, reinforcing their role as baseline therapies.
Nevertheless, the market faces several constraints. Extensive genericization has intensified price competition, compressing margins and limiting incentives for further innovation. Clinically, alternative delivery methods demonstrate improved adherence or performance in specific treatment phases, gradually diverting part of the demand. In addition, changes in reimbursement policies, centralized procurement mechanisms, and tightening regulatory requirements impose periodic pressure on market performance across regions, resulting in a market environment characterized by stability accompanied by ongoing challenges.
LP Information, Inc. (LPI) ' newest research report, the ?Progesterone Capsules Industry Forecast? looks at past sales and reviews total world Progesterone Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Progesterone Capsules sales for 2026 through 2032. With Progesterone Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Progesterone Capsules industry.
This Insight Report provides a comprehensive analysis of the global Progesterone Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Progesterone Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Progesterone Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Progesterone Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Progesterone Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Progesterone Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Progesterone Capsules market?
What factors are driving Progesterone Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Progesterone Capsules market opportunities vary by end market size?
How does Progesterone Capsules break out by Type, by Application?
Progesterone Capsules are oral solid dosage forms containing progesterone, widely used for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and selected hormone replacement therapy regimens. The dosage form has a long clinical history and well-established prescribing practices. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), gelatin or plant-based capsule shells, oil-based solvent systems such as vegetable oils or medium-chain triglycerides, antioxidants and stabilizers, as well as pharmaceutical blister packaging materials; overall material costs are relatively low, while formulation stability and oral bioavailability management represent the main technical considerations. Downstream customers mainly include OB-GYN hospitals, fertility clinics, general hospital outpatient departments, and retail prescription pharmacies, with additional use in peri-menopausal hormone therapy in certain markets. The global nameplate capacity for Progesterone Capsules in 2025 is estimated at approximately 0.98 billion capsules, with actual sales of around 0.86 billion capsules. Driven by a high share of generics and intense regional competition, the global average ex-factory price is estimated at USD 0.38 per capsule. Overall industry gross margin is estimated at approximately 46%.
The market is currently in a highly mature and intensely competitive stage, characterized by a multi-regional supply base and a large number of active manufacturers. Generic products dominate, making price and accessibility the primary competitive factors. Clinical use patterns are well established and widely distributed across routine OB-GYN care and reproductive medicine settings, with limited dependence on individual brands. In most markets, progesterone capsules are regarded as standard therapies, and purchasing and prescribing behaviors are increasingly rational, with market fluctuations driven more by policy and channel dynamics than by fundamental shifts in clinical demand.
Looking ahead, overall demand is expected to follow a moderate and stable trajectory rather than experiencing significant expansion. As assisted reproduction and women?s healthcare services become more standardized, oral progesterone will continue to play a role within established treatment pathways. However, in certain clinical scenarios that emphasize patient compliance or treatment optimization, its relative advantages are being challenged by alternative dosage forms. Regionally, improving access in emerging markets will remain a key source of support, while mature markets place greater emphasis on individualized treatment strategies and patient experience.
Key growth drivers include demographic changes, delayed childbearing trends, and rising awareness of women's health, all of which provide a degree of long-term resilience to underlying demand. At the same time, a well-developed API and formulation supply chain has lowered production and entry barriers, ensuring consistent product availability. From a healthcare system perspective, mature oral formulations continue to offer advantages in cost control and ease of use, reinforcing their role as baseline therapies.
Nevertheless, the market faces several constraints. Extensive genericization has intensified price competition, compressing margins and limiting incentives for further innovation. Clinically, alternative delivery methods demonstrate improved adherence or performance in specific treatment phases, gradually diverting part of the demand. In addition, changes in reimbursement policies, centralized procurement mechanisms, and tightening regulatory requirements impose periodic pressure on market performance across regions, resulting in a market environment characterized by stability accompanied by ongoing challenges.
LP Information, Inc. (LPI) ' newest research report, the ?Progesterone Capsules Industry Forecast? looks at past sales and reviews total world Progesterone Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Progesterone Capsules sales for 2026 through 2032. With Progesterone Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Progesterone Capsules industry.
This Insight Report provides a comprehensive analysis of the global Progesterone Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Progesterone Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Progesterone Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Progesterone Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Progesterone Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Progesterone Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Originator Products
- Branded Generics
- 6 Capsules Per Bottle
- 12 Capsules Per Bottle
- 30 Capsules Per Bottle
- Others
- Luteal Phase Support in Assisted Reproductive Technology
- Treatment of Luteal Phase Deficiency
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Viatris
- Teva Pharmaceutical Industries
- Besins Healthcare
- Organon
- Sun Pharmaceutical Industries
- Zydus Lifesciences
- Cipla
- Lupin
- Zhejiang Xianju Pharmaceutical
- Zhejiang Medicine
- Zhejiang Shenzhou Pharmaceutical
- Beijing Foyou Pharma
- Humanwell PuraCap Pharmaceuticals
What is the 10-year outlook for the global Progesterone Capsules market?
What factors are driving Progesterone Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Progesterone Capsules market opportunities vary by end market size?
How does Progesterone Capsules break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Progesterone Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Progesterone Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Progesterone Capsules by Country/Region, 2021, 2025 & 2032
2.2 Progesterone Capsules Segment by Type
2.2.1 Originator Products
2.2.2 Branded Generics
2.2.3 Progesterone Capsules Sales by Type
2.2.3.1 Global Progesterone Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Progesterone Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Progesterone Capsules Sale Price by Type (2021-2026)
2.3 Progesterone Capsules Segment by Dosage
2.3.1 6 Capsules Per Bottle
2.3.2 12 Capsules Per Bottle
2.3.3 30 Capsules Per Bottle
2.3.4 Others
2.3.5 Progesterone Capsules Sales by Dosage
2.3.5.1 Global Progesterone Capsules Sales Market Share by Dosage (2021-2026)
2.3.5.2 Global Progesterone Capsules Revenue and Market Share by Dosage (2021-2026)
2.3.5.3 Global Progesterone Capsules Sale Price by Dosage (2021-2026)
2.4 Progesterone Capsules Segment by Clinical Indication
2.4.1 Luteal Phase Support in Assisted Reproductive Technology
2.4.2 Treatment of Luteal Phase Deficiency
2.4.3 Others
2.4.4 Progesterone Capsules Sales by Clinical Indication
2.4.4.1 Global Progesterone Capsules Sales Market Share by Clinical Indication (2021-2026)
2.4.4.2 Global Progesterone Capsules Revenue and Market Share by Clinical Indication (2021-2026)
2.4.4.3 Global Progesterone Capsules Sale Price by Clinical Indication (2021-2026)
2.5 Progesterone Capsules Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 Progesterone Capsules Sales by Application
2.5.4.1 Global Progesterone Capsules Sale Market Share by Application (2021-2026)
2.5.4.2 Global Progesterone Capsules Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Progesterone Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Progesterone Capsules Breakdown Data by Company
3.1.1 Global Progesterone Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Progesterone Capsules Sales Market Share by Company (2021-2026)
3.2 Global Progesterone Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Progesterone Capsules Revenue by Company (2021-2026)
3.2.2 Global Progesterone Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Progesterone Capsules Sale Price by Company
3.4 Key Manufacturers Progesterone Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Progesterone Capsules Product Location Distribution
3.4.2 Players Progesterone Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROGESTERONE CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Progesterone Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Progesterone Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Progesterone Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Progesterone Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Progesterone Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Progesterone Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Progesterone Capsules Sales Growth
4.4 APAC Progesterone Capsules Sales Growth
4.5 Europe Progesterone Capsules Sales Growth
4.6 Middle East & Africa Progesterone Capsules Sales Growth
5 AMERICAS
5.1 Americas Progesterone Capsules Sales by Country
5.1.1 Americas Progesterone Capsules Sales by Country (2021-2026)
5.1.2 Americas Progesterone Capsules Revenue by Country (2021-2026)
5.2 Americas Progesterone Capsules Sales by Type (2021-2026)
5.3 Americas Progesterone Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Progesterone Capsules Sales by Region
6.1.1 APAC Progesterone Capsules Sales by Region (2021-2026)
6.1.2 APAC Progesterone Capsules Revenue by Region (2021-2026)
6.2 APAC Progesterone Capsules Sales by Type (2021-2026)
6.3 APAC Progesterone Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Progesterone Capsules by Country
7.1.1 Europe Progesterone Capsules Sales by Country (2021-2026)
7.1.2 Europe Progesterone Capsules Revenue by Country (2021-2026)
7.2 Europe Progesterone Capsules Sales by Type (2021-2026)
7.3 Europe Progesterone Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Progesterone Capsules by Country
8.1.1 Middle East & Africa Progesterone Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Progesterone Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Progesterone Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Progesterone Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Progesterone Capsules
10.3 Manufacturing Process Analysis of Progesterone Capsules
10.4 Industry Chain Structure of Progesterone Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Progesterone Capsules Distributors
11.3 Progesterone Capsules Customer
12 WORLD FORECAST REVIEW FOR PROGESTERONE CAPSULES BY GEOGRAPHIC REGION
12.1 Global Progesterone Capsules Market Size Forecast by Region
12.1.1 Global Progesterone Capsules Forecast by Region (2027-2032)
12.1.2 Global Progesterone Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Progesterone Capsules Forecast by Type (2027-2032)
12.7 Global Progesterone Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Progesterone Capsules Product Portfolios and Specifications
13.1.3 AbbVie Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Viatris
13.2.1 Viatris Company Information
13.2.2 Viatris Progesterone Capsules Product Portfolios and Specifications
13.2.3 Viatris Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Viatris Main Business Overview
13.2.5 Viatris Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 Besins Healthcare
13.4.1 Besins Healthcare Company Information
13.4.2 Besins Healthcare Progesterone Capsules Product Portfolios and Specifications
13.4.3 Besins Healthcare Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Besins Healthcare Main Business Overview
13.4.5 Besins Healthcare Latest Developments
13.5 Organon
13.5.1 Organon Company Information
13.5.2 Organon Progesterone Capsules Product Portfolios and Specifications
13.5.3 Organon Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Organon Main Business Overview
13.5.5 Organon Latest Developments
13.6 Sun Pharmaceutical Industries
13.6.1 Sun Pharmaceutical Industries Company Information
13.6.2 Sun Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Industries Main Business Overview
13.6.5 Sun Pharmaceutical Industries Latest Developments
13.7 Zydus Lifesciences
13.7.1 Zydus Lifesciences Company Information
13.7.2 Zydus Lifesciences Progesterone Capsules Product Portfolios and Specifications
13.7.3 Zydus Lifesciences Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zydus Lifesciences Main Business Overview
13.7.5 Zydus Lifesciences Latest Developments
13.8 Cipla
13.8.1 Cipla Company Information
13.8.2 Cipla Progesterone Capsules Product Portfolios and Specifications
13.8.3 Cipla Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cipla Main Business Overview
13.8.5 Cipla Latest Developments
13.9 Lupin
13.9.1 Lupin Company Information
13.9.2 Lupin Progesterone Capsules Product Portfolios and Specifications
13.9.3 Lupin Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lupin Main Business Overview
13.9.5 Lupin Latest Developments
13.10 Zhejiang Xianju Pharmaceutical
13.10.1 Zhejiang Xianju Pharmaceutical Company Information
13.10.2 Zhejiang Xianju Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
13.10.3 Zhejiang Xianju Pharmaceutical Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.10.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.11 Zhejiang Medicine
13.11.1 Zhejiang Medicine Company Information
13.11.2 Zhejiang Medicine Progesterone Capsules Product Portfolios and Specifications
13.11.3 Zhejiang Medicine Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zhejiang Medicine Main Business Overview
13.11.5 Zhejiang Medicine Latest Developments
13.12 Zhejiang Shenzhou Pharmaceutical
13.12.1 Zhejiang Shenzhou Pharmaceutical Company Information
13.12.2 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
13.12.3 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Shenzhou Pharmaceutical Main Business Overview
13.12.5 Zhejiang Shenzhou Pharmaceutical Latest Developments
13.13 Beijing Foyou Pharma
13.13.1 Beijing Foyou Pharma Company Information
13.13.2 Beijing Foyou Pharma Progesterone Capsules Product Portfolios and Specifications
13.13.3 Beijing Foyou Pharma Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Beijing Foyou Pharma Main Business Overview
13.13.5 Beijing Foyou Pharma Latest Developments
13.14 Humanwell PuraCap Pharmaceuticals
13.14.1 Humanwell PuraCap Pharmaceuticals Company Information
13.14.2 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product Portfolios and Specifications
13.14.3 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Humanwell PuraCap Pharmaceuticals Main Business Overview
13.14.5 Humanwell PuraCap Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Progesterone Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Progesterone Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Progesterone Capsules by Country/Region, 2021, 2025 & 2032
2.2 Progesterone Capsules Segment by Type
2.2.1 Originator Products
2.2.2 Branded Generics
2.2.3 Progesterone Capsules Sales by Type
2.2.3.1 Global Progesterone Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Progesterone Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Progesterone Capsules Sale Price by Type (2021-2026)
2.3 Progesterone Capsules Segment by Dosage
2.3.1 6 Capsules Per Bottle
2.3.2 12 Capsules Per Bottle
2.3.3 30 Capsules Per Bottle
2.3.4 Others
2.3.5 Progesterone Capsules Sales by Dosage
2.3.5.1 Global Progesterone Capsules Sales Market Share by Dosage (2021-2026)
2.3.5.2 Global Progesterone Capsules Revenue and Market Share by Dosage (2021-2026)
2.3.5.3 Global Progesterone Capsules Sale Price by Dosage (2021-2026)
2.4 Progesterone Capsules Segment by Clinical Indication
2.4.1 Luteal Phase Support in Assisted Reproductive Technology
2.4.2 Treatment of Luteal Phase Deficiency
2.4.3 Others
2.4.4 Progesterone Capsules Sales by Clinical Indication
2.4.4.1 Global Progesterone Capsules Sales Market Share by Clinical Indication (2021-2026)
2.4.4.2 Global Progesterone Capsules Revenue and Market Share by Clinical Indication (2021-2026)
2.4.4.3 Global Progesterone Capsules Sale Price by Clinical Indication (2021-2026)
2.5 Progesterone Capsules Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 Progesterone Capsules Sales by Application
2.5.4.1 Global Progesterone Capsules Sale Market Share by Application (2021-2026)
2.5.4.2 Global Progesterone Capsules Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Progesterone Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Progesterone Capsules Breakdown Data by Company
3.1.1 Global Progesterone Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Progesterone Capsules Sales Market Share by Company (2021-2026)
3.2 Global Progesterone Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Progesterone Capsules Revenue by Company (2021-2026)
3.2.2 Global Progesterone Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Progesterone Capsules Sale Price by Company
3.4 Key Manufacturers Progesterone Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Progesterone Capsules Product Location Distribution
3.4.2 Players Progesterone Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROGESTERONE CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Progesterone Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Progesterone Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Progesterone Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Progesterone Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Progesterone Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Progesterone Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Progesterone Capsules Sales Growth
4.4 APAC Progesterone Capsules Sales Growth
4.5 Europe Progesterone Capsules Sales Growth
4.6 Middle East & Africa Progesterone Capsules Sales Growth
5 AMERICAS
5.1 Americas Progesterone Capsules Sales by Country
5.1.1 Americas Progesterone Capsules Sales by Country (2021-2026)
5.1.2 Americas Progesterone Capsules Revenue by Country (2021-2026)
5.2 Americas Progesterone Capsules Sales by Type (2021-2026)
5.3 Americas Progesterone Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Progesterone Capsules Sales by Region
6.1.1 APAC Progesterone Capsules Sales by Region (2021-2026)
6.1.2 APAC Progesterone Capsules Revenue by Region (2021-2026)
6.2 APAC Progesterone Capsules Sales by Type (2021-2026)
6.3 APAC Progesterone Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Progesterone Capsules by Country
7.1.1 Europe Progesterone Capsules Sales by Country (2021-2026)
7.1.2 Europe Progesterone Capsules Revenue by Country (2021-2026)
7.2 Europe Progesterone Capsules Sales by Type (2021-2026)
7.3 Europe Progesterone Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Progesterone Capsules by Country
8.1.1 Middle East & Africa Progesterone Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Progesterone Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Progesterone Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Progesterone Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Progesterone Capsules
10.3 Manufacturing Process Analysis of Progesterone Capsules
10.4 Industry Chain Structure of Progesterone Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Progesterone Capsules Distributors
11.3 Progesterone Capsules Customer
12 WORLD FORECAST REVIEW FOR PROGESTERONE CAPSULES BY GEOGRAPHIC REGION
12.1 Global Progesterone Capsules Market Size Forecast by Region
12.1.1 Global Progesterone Capsules Forecast by Region (2027-2032)
12.1.2 Global Progesterone Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Progesterone Capsules Forecast by Type (2027-2032)
12.7 Global Progesterone Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Progesterone Capsules Product Portfolios and Specifications
13.1.3 AbbVie Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Viatris
13.2.1 Viatris Company Information
13.2.2 Viatris Progesterone Capsules Product Portfolios and Specifications
13.2.3 Viatris Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Viatris Main Business Overview
13.2.5 Viatris Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 Besins Healthcare
13.4.1 Besins Healthcare Company Information
13.4.2 Besins Healthcare Progesterone Capsules Product Portfolios and Specifications
13.4.3 Besins Healthcare Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Besins Healthcare Main Business Overview
13.4.5 Besins Healthcare Latest Developments
13.5 Organon
13.5.1 Organon Company Information
13.5.2 Organon Progesterone Capsules Product Portfolios and Specifications
13.5.3 Organon Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Organon Main Business Overview
13.5.5 Organon Latest Developments
13.6 Sun Pharmaceutical Industries
13.6.1 Sun Pharmaceutical Industries Company Information
13.6.2 Sun Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Industries Main Business Overview
13.6.5 Sun Pharmaceutical Industries Latest Developments
13.7 Zydus Lifesciences
13.7.1 Zydus Lifesciences Company Information
13.7.2 Zydus Lifesciences Progesterone Capsules Product Portfolios and Specifications
13.7.3 Zydus Lifesciences Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zydus Lifesciences Main Business Overview
13.7.5 Zydus Lifesciences Latest Developments
13.8 Cipla
13.8.1 Cipla Company Information
13.8.2 Cipla Progesterone Capsules Product Portfolios and Specifications
13.8.3 Cipla Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cipla Main Business Overview
13.8.5 Cipla Latest Developments
13.9 Lupin
13.9.1 Lupin Company Information
13.9.2 Lupin Progesterone Capsules Product Portfolios and Specifications
13.9.3 Lupin Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lupin Main Business Overview
13.9.5 Lupin Latest Developments
13.10 Zhejiang Xianju Pharmaceutical
13.10.1 Zhejiang Xianju Pharmaceutical Company Information
13.10.2 Zhejiang Xianju Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
13.10.3 Zhejiang Xianju Pharmaceutical Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.10.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.11 Zhejiang Medicine
13.11.1 Zhejiang Medicine Company Information
13.11.2 Zhejiang Medicine Progesterone Capsules Product Portfolios and Specifications
13.11.3 Zhejiang Medicine Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zhejiang Medicine Main Business Overview
13.11.5 Zhejiang Medicine Latest Developments
13.12 Zhejiang Shenzhou Pharmaceutical
13.12.1 Zhejiang Shenzhou Pharmaceutical Company Information
13.12.2 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
13.12.3 Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Shenzhou Pharmaceutical Main Business Overview
13.12.5 Zhejiang Shenzhou Pharmaceutical Latest Developments
13.13 Beijing Foyou Pharma
13.13.1 Beijing Foyou Pharma Company Information
13.13.2 Beijing Foyou Pharma Progesterone Capsules Product Portfolios and Specifications
13.13.3 Beijing Foyou Pharma Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Beijing Foyou Pharma Main Business Overview
13.13.5 Beijing Foyou Pharma Latest Developments
13.14 Humanwell PuraCap Pharmaceuticals
13.14.1 Humanwell PuraCap Pharmaceuticals Company Information
13.14.2 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product Portfolios and Specifications
13.14.3 Humanwell PuraCap Pharmaceuticals Progesterone Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Humanwell PuraCap Pharmaceuticals Main Business Overview
13.14.5 Humanwell PuraCap Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Progesterone Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Progesterone Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Originator Products
Table 4. Major Players of Branded Generics
Table 5. Global Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Progesterone Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Progesterone Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Progesterone Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Progesterone Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 6 Capsules Per Bottle
Table 11. Major Players of 12 Capsules Per Bottle
Table 12. Major Players of 30 Capsules Per Bottle
Table 13. Major Players of Others
Table 14. Global Progesterone Capsules Sales by Dosage (2021-2026) & (K Units)
Table 15. Global Progesterone Capsules Sales Market Share by Dosage (2021-2026)
Table 16. Global Progesterone Capsules Revenue by Dosage (2021-2026) & ($ million)
Table 17. Global Progesterone Capsules Revenue Market Share by Dosage (2021-2026)
Table 18. Global Progesterone Capsules Sale Price by Dosage (2021-2026) & (US$/Unit)
Table 19. Major Players of Luteal Phase Support in Assisted Reproductive Technology
Table 20. Major Players of Treatment of Luteal Phase Deficiency
Table 21. Major Players of Others
Table 22. Global Progesterone Capsules Sales by Clinical Indication (2021-2026) & (K Units)
Table 23. Global Progesterone Capsules Sales Market Share by Clinical Indication (2021-2026)
Table 24. Global Progesterone Capsules Revenue by Clinical Indication (2021-2026) & ($ million)
Table 25. Global Progesterone Capsules Revenue Market Share by Clinical Indication (2021-2026)
Table 26. Global Progesterone Capsules Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 27. Global Progesterone Capsules Sale by Application (2021-2026) & (K Units)
Table 28. Global Progesterone Capsules Sale Market Share by Application (2021-2026)
Table 29. Global Progesterone Capsules Revenue by Application (2021-2026) & ($ million)
Table 30. Global Progesterone Capsules Revenue Market Share by Application (2021-2026)
Table 31. Global Progesterone Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Progesterone Capsules Sales by Company (2021-2026) & (K Units)
Table 33. Global Progesterone Capsules Sales Market Share by Company (2021-2026)
Table 34. Global Progesterone Capsules Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Progesterone Capsules Revenue Market Share by Company (2021-2026)
Table 36. Global Progesterone Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Progesterone Capsules Producing Area Distribution and Sales Area
Table 38. Players Progesterone Capsules Products Offered
Table 39. Progesterone Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Progesterone Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Progesterone Capsules Sales Market Share Geographic Region (2021-2026)
Table 44. Global Progesterone Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Progesterone Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Progesterone Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Progesterone Capsules Sales Market Share by Country/Region (2021-2026)
Table 48. Global Progesterone Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Progesterone Capsules Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Progesterone Capsules Sales by Country (2021-2026) & (K Units)
Table 51. Americas Progesterone Capsules Sales Market Share by Country (2021-2026)
Table 52. Americas Progesterone Capsules Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 54. Americas Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 55. APAC Progesterone Capsules Sales by Region (2021-2026) & (K Units)
Table 56. APAC Progesterone Capsules Sales Market Share by Region (2021-2026)
Table 57. APAC Progesterone Capsules Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 59. APAC Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 60. Europe Progesterone Capsules Sales by Country (2021-2026) & (K Units)
Table 61. Europe Progesterone Capsules Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 63. Europe Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Progesterone Capsules Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Progesterone Capsules Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Progesterone Capsules
Table 69. Key Market Challenges & Risks of Progesterone Capsules
Table 70. Key Industry Trends of Progesterone Capsules
Table 71. Progesterone Capsules Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Progesterone Capsules Distributors List
Table 74. Progesterone Capsules Customer List
Table 75. Global Progesterone Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Progesterone Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Progesterone Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Progesterone Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Progesterone Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Progesterone Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Progesterone Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Progesterone Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Progesterone Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Progesterone Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Progesterone Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Progesterone Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Progesterone Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Progesterone Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. AbbVie Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 90. AbbVie Progesterone Capsules Product Portfolios and Specifications
Table 91. AbbVie Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. AbbVie Main Business
Table 93. AbbVie Latest Developments
Table 94. Viatris Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 95. Viatris Progesterone Capsules Product Portfolios and Specifications
Table 96. Viatris Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Viatris Main Business
Table 98. Viatris Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
Table 101. Teva Pharmaceutical Industries Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Teva Pharmaceutical Industries Main Business
Table 103. Teva Pharmaceutical Industries Latest Developments
Table 104. Besins Healthcare Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 105. Besins Healthcare Progesterone Capsules Product Portfolios and Specifications
Table 106. Besins Healthcare Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Besins Healthcare Main Business
Table 108. Besins Healthcare Latest Developments
Table 109. Organon Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 110. Organon Progesterone Capsules Product Portfolios and Specifications
Table 111. Organon Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Organon Main Business
Table 113. Organon Latest Developments
Table 114. Sun Pharmaceutical Industries Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 115. Sun Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
Table 116. Sun Pharmaceutical Industries Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sun Pharmaceutical Industries Main Business
Table 118. Sun Pharmaceutical Industries Latest Developments
Table 119. Zydus Lifesciences Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 120. Zydus Lifesciences Progesterone Capsules Product Portfolios and Specifications
Table 121. Zydus Lifesciences Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Zydus Lifesciences Main Business
Table 123. Zydus Lifesciences Latest Developments
Table 124. Cipla Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 125. Cipla Progesterone Capsules Product Portfolios and Specifications
Table 126. Cipla Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Cipla Main Business
Table 128. Cipla Latest Developments
Table 129. Lupin Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 130. Lupin Progesterone Capsules Product Portfolios and Specifications
Table 131. Lupin Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Lupin Main Business
Table 133. Lupin Latest Developments
Table 134. Zhejiang Xianju Pharmaceutical Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhejiang Xianju Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
Table 136. Zhejiang Xianju Pharmaceutical Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Zhejiang Xianju Pharmaceutical Main Business
Table 138. Zhejiang Xianju Pharmaceutical Latest Developments
Table 139. Zhejiang Medicine Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 140. Zhejiang Medicine Progesterone Capsules Product Portfolios and Specifications
Table 141. Zhejiang Medicine Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Zhejiang Medicine Main Business
Table 143. Zhejiang Medicine Latest Developments
Table 144. Zhejiang Shenzhou Pharmaceutical Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 145. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
Table 146. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Zhejiang Shenzhou Pharmaceutical Main Business
Table 148. Zhejiang Shenzhou Pharmaceutical Latest Developments
Table 149. Beijing Foyou Pharma Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 150. Beijing Foyou Pharma Progesterone Capsules Product Portfolios and Specifications
Table 151. Beijing Foyou Pharma Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Beijing Foyou Pharma Main Business
Table 153. Beijing Foyou Pharma Latest Developments
Table 154. Humanwell PuraCap Pharmaceuticals Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 155. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product Portfolios and Specifications
Table 156. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Humanwell PuraCap Pharmaceuticals Main Business
Table 158. Humanwell PuraCap Pharmaceuticals Latest Developments
Table 1. Progesterone Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Progesterone Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Originator Products
Table 4. Major Players of Branded Generics
Table 5. Global Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Progesterone Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Progesterone Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Progesterone Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Progesterone Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 6 Capsules Per Bottle
Table 11. Major Players of 12 Capsules Per Bottle
Table 12. Major Players of 30 Capsules Per Bottle
Table 13. Major Players of Others
Table 14. Global Progesterone Capsules Sales by Dosage (2021-2026) & (K Units)
Table 15. Global Progesterone Capsules Sales Market Share by Dosage (2021-2026)
Table 16. Global Progesterone Capsules Revenue by Dosage (2021-2026) & ($ million)
Table 17. Global Progesterone Capsules Revenue Market Share by Dosage (2021-2026)
Table 18. Global Progesterone Capsules Sale Price by Dosage (2021-2026) & (US$/Unit)
Table 19. Major Players of Luteal Phase Support in Assisted Reproductive Technology
Table 20. Major Players of Treatment of Luteal Phase Deficiency
Table 21. Major Players of Others
Table 22. Global Progesterone Capsules Sales by Clinical Indication (2021-2026) & (K Units)
Table 23. Global Progesterone Capsules Sales Market Share by Clinical Indication (2021-2026)
Table 24. Global Progesterone Capsules Revenue by Clinical Indication (2021-2026) & ($ million)
Table 25. Global Progesterone Capsules Revenue Market Share by Clinical Indication (2021-2026)
Table 26. Global Progesterone Capsules Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 27. Global Progesterone Capsules Sale by Application (2021-2026) & (K Units)
Table 28. Global Progesterone Capsules Sale Market Share by Application (2021-2026)
Table 29. Global Progesterone Capsules Revenue by Application (2021-2026) & ($ million)
Table 30. Global Progesterone Capsules Revenue Market Share by Application (2021-2026)
Table 31. Global Progesterone Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Progesterone Capsules Sales by Company (2021-2026) & (K Units)
Table 33. Global Progesterone Capsules Sales Market Share by Company (2021-2026)
Table 34. Global Progesterone Capsules Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Progesterone Capsules Revenue Market Share by Company (2021-2026)
Table 36. Global Progesterone Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Progesterone Capsules Producing Area Distribution and Sales Area
Table 38. Players Progesterone Capsules Products Offered
Table 39. Progesterone Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Progesterone Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Progesterone Capsules Sales Market Share Geographic Region (2021-2026)
Table 44. Global Progesterone Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Progesterone Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Progesterone Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Progesterone Capsules Sales Market Share by Country/Region (2021-2026)
Table 48. Global Progesterone Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Progesterone Capsules Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Progesterone Capsules Sales by Country (2021-2026) & (K Units)
Table 51. Americas Progesterone Capsules Sales Market Share by Country (2021-2026)
Table 52. Americas Progesterone Capsules Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 54. Americas Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 55. APAC Progesterone Capsules Sales by Region (2021-2026) & (K Units)
Table 56. APAC Progesterone Capsules Sales Market Share by Region (2021-2026)
Table 57. APAC Progesterone Capsules Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 59. APAC Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 60. Europe Progesterone Capsules Sales by Country (2021-2026) & (K Units)
Table 61. Europe Progesterone Capsules Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 63. Europe Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Progesterone Capsules Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Progesterone Capsules Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Progesterone Capsules Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Progesterone Capsules Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Progesterone Capsules
Table 69. Key Market Challenges & Risks of Progesterone Capsules
Table 70. Key Industry Trends of Progesterone Capsules
Table 71. Progesterone Capsules Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Progesterone Capsules Distributors List
Table 74. Progesterone Capsules Customer List
Table 75. Global Progesterone Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Progesterone Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Progesterone Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Progesterone Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Progesterone Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Progesterone Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Progesterone Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Progesterone Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Progesterone Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Progesterone Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Progesterone Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Progesterone Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Progesterone Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Progesterone Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. AbbVie Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 90. AbbVie Progesterone Capsules Product Portfolios and Specifications
Table 91. AbbVie Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. AbbVie Main Business
Table 93. AbbVie Latest Developments
Table 94. Viatris Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 95. Viatris Progesterone Capsules Product Portfolios and Specifications
Table 96. Viatris Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Viatris Main Business
Table 98. Viatris Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
Table 101. Teva Pharmaceutical Industries Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Teva Pharmaceutical Industries Main Business
Table 103. Teva Pharmaceutical Industries Latest Developments
Table 104. Besins Healthcare Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 105. Besins Healthcare Progesterone Capsules Product Portfolios and Specifications
Table 106. Besins Healthcare Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Besins Healthcare Main Business
Table 108. Besins Healthcare Latest Developments
Table 109. Organon Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 110. Organon Progesterone Capsules Product Portfolios and Specifications
Table 111. Organon Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Organon Main Business
Table 113. Organon Latest Developments
Table 114. Sun Pharmaceutical Industries Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 115. Sun Pharmaceutical Industries Progesterone Capsules Product Portfolios and Specifications
Table 116. Sun Pharmaceutical Industries Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sun Pharmaceutical Industries Main Business
Table 118. Sun Pharmaceutical Industries Latest Developments
Table 119. Zydus Lifesciences Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 120. Zydus Lifesciences Progesterone Capsules Product Portfolios and Specifications
Table 121. Zydus Lifesciences Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Zydus Lifesciences Main Business
Table 123. Zydus Lifesciences Latest Developments
Table 124. Cipla Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 125. Cipla Progesterone Capsules Product Portfolios and Specifications
Table 126. Cipla Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Cipla Main Business
Table 128. Cipla Latest Developments
Table 129. Lupin Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 130. Lupin Progesterone Capsules Product Portfolios and Specifications
Table 131. Lupin Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Lupin Main Business
Table 133. Lupin Latest Developments
Table 134. Zhejiang Xianju Pharmaceutical Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhejiang Xianju Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
Table 136. Zhejiang Xianju Pharmaceutical Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Zhejiang Xianju Pharmaceutical Main Business
Table 138. Zhejiang Xianju Pharmaceutical Latest Developments
Table 139. Zhejiang Medicine Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 140. Zhejiang Medicine Progesterone Capsules Product Portfolios and Specifications
Table 141. Zhejiang Medicine Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Zhejiang Medicine Main Business
Table 143. Zhejiang Medicine Latest Developments
Table 144. Zhejiang Shenzhou Pharmaceutical Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 145. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Product Portfolios and Specifications
Table 146. Zhejiang Shenzhou Pharmaceutical Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Zhejiang Shenzhou Pharmaceutical Main Business
Table 148. Zhejiang Shenzhou Pharmaceutical Latest Developments
Table 149. Beijing Foyou Pharma Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 150. Beijing Foyou Pharma Progesterone Capsules Product Portfolios and Specifications
Table 151. Beijing Foyou Pharma Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Beijing Foyou Pharma Main Business
Table 153. Beijing Foyou Pharma Latest Developments
Table 154. Humanwell PuraCap Pharmaceuticals Basic Information, Progesterone Capsules Manufacturing Base, Sales Area and Its Competitors
Table 155. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Product Portfolios and Specifications
Table 156. Humanwell PuraCap Pharmaceuticals Progesterone Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Humanwell PuraCap Pharmaceuticals Main Business
Table 158. Humanwell PuraCap Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Progesterone Capsules
Figure 2. Progesterone Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Progesterone Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Progesterone Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Progesterone Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Progesterone Capsules Sales Market Share by Country/Region (2025)
Figure 10. Progesterone Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Originator Products
Figure 12. Product Picture of Branded Generics
Figure 13. Global Progesterone Capsules Sales Market Share by Type in 2026
Figure 14. Global Progesterone Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 6 Capsules Per Bottle
Figure 16. Product Picture of 12 Capsules Per Bottle
Figure 17. Product Picture of 30 Capsules Per Bottle
Figure 18. Product Picture of Others
Figure 19. Global Progesterone Capsules Sales Market Share by Dosage in 2026
Figure 20. Global Progesterone Capsules Revenue Market Share by Dosage (2021-2026)
Figure 21. Product Picture of Luteal Phase Support in Assisted Reproductive Technology
Figure 22. Product Picture of Treatment of Luteal Phase Deficiency
Figure 23. Product Picture of Others
Figure 24. Global Progesterone Capsules Sales Market Share by Clinical Indication in 2026
Figure 25. Global Progesterone Capsules Revenue Market Share by Clinical Indication (2021-2026)
Figure 26. Progesterone Capsules Consumed in Hospital
Figure 27. Global Progesterone Capsules Market: Hospital (2021-2026) & (K Units)
Figure 28. Progesterone Capsules Consumed in Clinic
Figure 29. Global Progesterone Capsules Market: Clinic (2021-2026) & (K Units)
Figure 30. Progesterone Capsules Consumed in Others
Figure 31. Global Progesterone Capsules Market: Others (2021-2026) & (K Units)
Figure 32. Global Progesterone Capsules Sale Market Share by Application (2025)
Figure 33. Global Progesterone Capsules Revenue Market Share by Application in 2025
Figure 34. Progesterone Capsules Sales by Company in 2025 (K Units)
Figure 35. Global Progesterone Capsules Sales Market Share by Company in 2025
Figure 36. Progesterone Capsules Revenue by Company in 2025 ($ millions)
Figure 37. Global Progesterone Capsules Revenue Market Share by Company in 2025
Figure 38. Global Progesterone Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Progesterone Capsules Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Progesterone Capsules Sales 2021-2026 (K Units)
Figure 41. Americas Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 42. APAC Progesterone Capsules Sales 2021-2026 (K Units)
Figure 43. APAC Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 44. Europe Progesterone Capsules Sales 2021-2026 (K Units)
Figure 45. Europe Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Progesterone Capsules Sales 2021-2026 (K Units)
Figure 47. Middle East & Africa Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 48. Americas Progesterone Capsules Sales Market Share by Country in 2025
Figure 49. Americas Progesterone Capsules Revenue Market Share by Country (2021-2026)
Figure 50. Americas Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 51. Americas Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 52. United States Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Progesterone Capsules Sales Market Share by Region in 2025
Figure 57. APAC Progesterone Capsules Revenue Market Share by Region (2021-2026)
Figure 58. APAC Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 59. APAC Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 60. China Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. India Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Progesterone Capsules Sales Market Share by Country in 2025
Figure 68. Europe Progesterone Capsules Revenue Market Share by Country (2021-2026)
Figure 69. Europe Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 70. Europe Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 71. Germany Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. France Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Progesterone Capsules Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 79. Egypt Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Progesterone Capsules in 2026
Figure 85. Manufacturing Process Analysis of Progesterone Capsules
Figure 86. Industry Chain Structure of Progesterone Capsules
Figure 87. Channels of Distribution
Figure 88. Global Progesterone Capsules Sales Market Forecast by Region (2027-2032)
Figure 89. Global Progesterone Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Progesterone Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Progesterone Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Progesterone Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Progesterone Capsules Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Progesterone Capsules
Figure 2. Progesterone Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Progesterone Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Progesterone Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Progesterone Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Progesterone Capsules Sales Market Share by Country/Region (2025)
Figure 10. Progesterone Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Originator Products
Figure 12. Product Picture of Branded Generics
Figure 13. Global Progesterone Capsules Sales Market Share by Type in 2026
Figure 14. Global Progesterone Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 6 Capsules Per Bottle
Figure 16. Product Picture of 12 Capsules Per Bottle
Figure 17. Product Picture of 30 Capsules Per Bottle
Figure 18. Product Picture of Others
Figure 19. Global Progesterone Capsules Sales Market Share by Dosage in 2026
Figure 20. Global Progesterone Capsules Revenue Market Share by Dosage (2021-2026)
Figure 21. Product Picture of Luteal Phase Support in Assisted Reproductive Technology
Figure 22. Product Picture of Treatment of Luteal Phase Deficiency
Figure 23. Product Picture of Others
Figure 24. Global Progesterone Capsules Sales Market Share by Clinical Indication in 2026
Figure 25. Global Progesterone Capsules Revenue Market Share by Clinical Indication (2021-2026)
Figure 26. Progesterone Capsules Consumed in Hospital
Figure 27. Global Progesterone Capsules Market: Hospital (2021-2026) & (K Units)
Figure 28. Progesterone Capsules Consumed in Clinic
Figure 29. Global Progesterone Capsules Market: Clinic (2021-2026) & (K Units)
Figure 30. Progesterone Capsules Consumed in Others
Figure 31. Global Progesterone Capsules Market: Others (2021-2026) & (K Units)
Figure 32. Global Progesterone Capsules Sale Market Share by Application (2025)
Figure 33. Global Progesterone Capsules Revenue Market Share by Application in 2025
Figure 34. Progesterone Capsules Sales by Company in 2025 (K Units)
Figure 35. Global Progesterone Capsules Sales Market Share by Company in 2025
Figure 36. Progesterone Capsules Revenue by Company in 2025 ($ millions)
Figure 37. Global Progesterone Capsules Revenue Market Share by Company in 2025
Figure 38. Global Progesterone Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Progesterone Capsules Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Progesterone Capsules Sales 2021-2026 (K Units)
Figure 41. Americas Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 42. APAC Progesterone Capsules Sales 2021-2026 (K Units)
Figure 43. APAC Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 44. Europe Progesterone Capsules Sales 2021-2026 (K Units)
Figure 45. Europe Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Progesterone Capsules Sales 2021-2026 (K Units)
Figure 47. Middle East & Africa Progesterone Capsules Revenue 2021-2026 ($ millions)
Figure 48. Americas Progesterone Capsules Sales Market Share by Country in 2025
Figure 49. Americas Progesterone Capsules Revenue Market Share by Country (2021-2026)
Figure 50. Americas Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 51. Americas Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 52. United States Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Progesterone Capsules Sales Market Share by Region in 2025
Figure 57. APAC Progesterone Capsules Revenue Market Share by Region (2021-2026)
Figure 58. APAC Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 59. APAC Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 60. China Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. India Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Progesterone Capsules Sales Market Share by Country in 2025
Figure 68. Europe Progesterone Capsules Revenue Market Share by Country (2021-2026)
Figure 69. Europe Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 70. Europe Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 71. Germany Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. France Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Progesterone Capsules Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Progesterone Capsules Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Progesterone Capsules Sales Market Share by Application (2021-2026)
Figure 79. Egypt Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Progesterone Capsules Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Progesterone Capsules in 2026
Figure 85. Manufacturing Process Analysis of Progesterone Capsules
Figure 86. Industry Chain Structure of Progesterone Capsules
Figure 87. Channels of Distribution
Figure 88. Global Progesterone Capsules Sales Market Forecast by Region (2027-2032)
Figure 89. Global Progesterone Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Progesterone Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Progesterone Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Progesterone Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Progesterone Capsules Revenue Market Share Forecast by Application (2027-2032)
